Abstract |
Cannabinoids classically act via CB₁ and CB₂ receptors to modulate nociception; however, recent findings suggest that some cannabinoids bind to atypical receptors. One such receptor is GPR55 which is activated by the abnormal cannabidiol analogue O-1602. This study investigated whether the synthetic GPR55 agonist O-1602 can alter joint nociception in a rat model of acute joint inflammation. Acute (24 h) inflammatory joint pain was induced in male Wistar rats by intra-articular injection of 2% kaolin and 2% carrageenan. Single unit extracellular recordings were made from arthritic joint afferents in response to mechanical rotation of the knee. Peripheral administration of O-1602 significantly reduced movement-evoked firing of nociceptive C fibres and this effect was blocked by the GPR55 receptor antagonist O-1918. Co-administration of the CB₁ and CB₂ antagonists (AM281 and AM630 respectively) had no effect on O-1602 responses. This study clearly shows that atypical cannabinoid receptors are involved in joint nociception and these novel targets may be advantageous for the treatment of inflammatory pain.
|
Authors | Niklas Schuelert, Jason J McDougall |
Journal | Neuroscience letters
(Neurosci Lett)
Vol. 500
Issue 1
Pg. 72-6
(Aug 01 2011)
ISSN: 1872-7972 [Electronic] Ireland |
PMID | 21683763
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Receptor, Cannabinoid, CB1
- Receptor, Cannabinoid, CB2
- Receptors, G-Protein-Coupled
- Cannabidiol
- Kaolin
- O-1602 compound
- Carrageenan
|
Topics |
- Action Potentials
- Acute Disease
- Afferent Pathways
- Animals
- Arthritis
(chemically induced, drug therapy, physiopathology)
- Cannabidiol
(analogs & derivatives, pharmacology)
- Carrageenan
- Hindlimb
- Joints
(drug effects, physiopathology)
- Kaolin
- Male
- Movement
- Nerve Fibers, Unmyelinated
(drug effects, physiology)
- Nociception
(drug effects)
- Rats
- Rats, Wistar
- Receptor, Cannabinoid, CB1
(antagonists & inhibitors)
- Receptor, Cannabinoid, CB2
(antagonists & inhibitors)
- Receptors, G-Protein-Coupled
(agonists, antagonists & inhibitors, physiology)
|